{"id":"W4410820157","doi":"10.1200/jco.2025.43.16_suppl.tps617","title":"Adjuvant WIDER: A phase 3b trial of ribociclib (RIB) + endocrine therapy (ET) as adjuvant treatment (tx) in a close-to-clinical-practice patient (pt) population with HR+/HER2− early breast cancer (EBC).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Adjuvant; Breast cancer; Cancer; Clinical Practice; Population; Oncology; Clinical trial; Internal medicine; Adjuvant therapy; Endocrine system; Gynecology; Surgery; Family medicine; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002823477,0.0004250769,0.003493862,0.0004090049,0.00005224948,0.00001671163,0.0002492277,0.0003652398,0.0001960713],"category_scores_gemma":[0.003258154,0.0002743274,0.0007527808,0.0005744186,0.0002827008,0.0003964537,0.00006809538,0.00128098,0.00000891894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001013802,"about_ca_system_score_gemma":0.004185921,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002023423,"about_ca_topic_score_gemma":0.0008284817,"domain_scores_codex":[0.991088,0.001622549,0.005419477,0.0005697465,0.0008045612,0.0004956366],"domain_scores_gemma":[0.9886966,0.005021562,0.004045788,0.0005376155,0.001162118,0.0005363587],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.3919838,0.01227983,0.04403108,0.00001732597,0.001080825,0.0006876497,0.0003943884,0.00008133502,0.0001193023,0.0001137325,0.000112197,0.5490985],"study_design_scores_gemma":[0.3674637,0.1408507,0.3964394,0.0009019651,0.000970941,0.0007096788,0.0004766524,0.00003867689,0.0002330534,0.0009233732,0.09071412,0.0002778005],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9616377,0.002186535,0.000204595,0.03167271,0.001933939,0.001759992,0.00004404662,0.00002309006,0.0005374395],"genre_scores_gemma":[0.9785194,0.005404249,0.006209035,0.008312237,0.001150988,0.0001193544,0.000009271547,0.00005310483,0.0002223113],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5488207,"threshold_uncertainty_score":0.9999709,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08150653700977262,"score_gpt":0.5433641036047657,"score_spread":0.4618575665949931,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}